Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Lymphoma

Here you will find summaries of a selection of ongoing clinical trials on lymphoma.

Trials with medicinal products

ALCL-VBL (anaplastic large cell lymphoma)  Clinical study into a new treatment for ALK+ anaplastic large cell lymphoma - open for inclusion

BIANCA (B-NHL)  Clinical study with tisagenlecleucel in children and adolescents with B-cell non-Hodgkin lymphoma (B-NHL) - closed for inclusion

BrigaPED (tumors with ALK defect)  Clinical study into the safety and effectiveness of brigatinib in children and young adults with ALK+ ALCL, IMT and other solid tumors with abnormalities in the ALK gene - open for inclusion

CA224-069 (cHL, NHL)  Clinical study towards a new treatment (relatlimab with nivolumab) in children, adolescents and young adults with classical Hodgkin lymphoma (cHL) and non-Hodgkin lymphoma (NHL) - open for inclusion

CRISP (tumors with ALK/MET/ROS1 abnormalities)  Clinical study of the safety and efficacy of the drug crizotinib in children, either alone or in combination with other drugs - open for inclusion

ESMART (different tumor types)  Clinical study in children with cancer into the safety and efficacy of drugs matching a specific DNA alteration in the tumor - open for inclusion

HEM-iSMART subprotocol D (ALL/LBL)  Clinical study of trametinib for children with relapsed or refractory leukemia or lymphoma with a RAS mutation - open for inclusion

Inotuzumab ITCC-059 (ALL/B-cell leukemia/lymphoma) Clinical study of the safety and efficacy of the drug Inotuzumab Ozogamicin (InO) in children with relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukemia (ALL) or other CD22-positive malignancies - open for inclusion

JCAR017-BCM-004 (B-ALL/B-NHL)  Clinical study to evaluate the safety and efficacy of JCAR017 in children with a special type of leukemia (B-ALL) and non-Hodgkin’s lymphoma - closed for inclusion

MK-3475-051 pembrolizumab (melanoma, solid tumor, lymphoma)  Clinical study with the study drug MK-3475 in children with skin cancer (melanoma), solid tumor or lymphoma - open for inclusion

NIVO-ALCL (Anaplastic large cell lymphoma)  Clinical study of a new treatment for ALK+ anaplastic large cell lymphoma (ALCL) - closed for inclusion

Nivolumab CA 209-744 (Hodgkin-lymphoma)  Clinical study of the safety, tolerability and efficacy of the drug nivolumab in combination with brentuximab vedotin in children with classic Hodgkin lymphoma - closed for inclusion

Ponatinib INCB084344 (leukemia/solid tumors)  Clinical study of the safety and efficacy of ponatinib for the treatment of different types of leukemia or solid tumors in children - open for inclusion

Venetoclax M13-833 (hematologic/solid tumors) Clinical study of the safety and efficacy of the drug venetoclax in children and young adults - closed for inclusion


Other trials

Breath analysis (hemato-oncological disease)A clinical pilot study of exhaled breath as an approach in the diagnostic work-up for an invasive fungal infection in the lungs of children with an impaired immune system - open for inclusion

DAVINCY (all cancer types)  Clinical study of extended use of the drug (fos)aprepitant to prevent chemotherapy-induced nausea and vomiting - open for inclusion

Dynamic FDG-PET  Clinical study to evaluate the use of dynamic FDG-PET scan in pediatric oncology - open for inclusion

FOCUS (all cancer types)  Clinical study to optimize dosing of fluconazole in children for the prevention or treatment of invasive fungal infections - open for inclusion

PINOCCHIO (multiple types of cancer)Clinical study in children on the metabolism, distribution and excretion of chemotherapy in the body, also called pharmacokinetics - open for inclusion

Tumor donation in Childhood Cancer patients  This study is designed to enable post-mortem tumor donation in children that die from all different types of pediatric solid and brain tumors, to enable research on end-stage disease - open for inclusion

VANISH  Clinical study of scans of fungal infections in the lungs - open for inclusion

VIKinG (AML & Burkitt lymphoma)  Clinical study of the gut microbiota as predictor for bloodstream infections in children with cancer - open for inclusion